fiercepharma.com
37/100
Ranked #40,853 of 46,880 sites
fiercepharma.com
37/100 · #40,853 of 46,880
homepagerankings.com
Media / Content / Publishing Benchmarks
How you compare to 6,908 Media / Content / Publishing sites
Gray line = Media / Content / Publishing median
Analysis
Fiercepharma scores 37 out of 100 on homepage messaging, earning a D grade — below average — significant gaps in clarity or targeting. Across all 30,134 sites analyzed, that's well below the median of 59. Within Media / Content / Publishing, where the median is 62, Fiercepharma lands 25 points below the industry average.
No hero text found. Visitors see nothing above the fold that tells them what you do.
The page has 2 CTAs, 2 of them above the fold. That's a focused set, which avoids overwhelming visitors. The primary CTA "Industry Events" is generic — 'Learn more' and 'Get started' don't tell visitors what happens next.
Audience targeting is decent — there are audience signals, but room to be more specific. Detected audience: Media / Content / Publishing, executive. Role words found: "executive". The site uses a "for [X]" pattern: "rare disease". ICP clarity score: 50 (above the median of 35).
The biggest opportunities for Fiercepharma: First impression clarity is below median — visitors can't quickly tell what category this product falls into.
Fix These First
up to +41 ptsRanked by estimated impact on your overall score
Add a pricing page
Hiding pricing creates friction — most buyers want to self-qualify before talking to sales
Add a clear hero headline
No hero headline detected — the most important real estate on your page is empty
Close first-impression gaps
Visitors can't quickly tell who it's for and what it does — those signals should be above the fold
Make your CTA more specific
"Get started" is generic — tie it to an outcome ("Start building" or "See your report")
Simplify your above-fold copy
Grade level 24 reads like an academic paper — aim for grade 8-10
First Impression
F (20/100)“A visitor would think this is a media / content / publishing for someone that offers something unclear.”
Media / Content / Publishing
Unknown
Unknown
Visibility / Insights
Neutral
Gaps:
- -Business category is implied but not clearly stated.
- -No clear target audience defined. Could be for anyone, which means it resonates with no one.
- -Product function unclear from above-fold copy. Visitors cannot tell what this does.
- -Value proposition is weakly communicated. Benefits are implied, not stated.
Suggested Rewrites
Better copy based on your product signals — click to copy
Current
Industry Events
Tying your CTA to a specific outcome increases click-through
A/B Test Ideas
Specific experiments to run, ranked by expected impact
Test adding "free" or "no card required" to your primary CTA
Risk-reducing modifiers typically lift click-through 10-15%
Test a "free" modifier on your CTA: "Industry Events" vs "Industry Events — Free"
"Free" is the highest-converting modifier across 27K+ homepages analyzed
Test adding a one-line product description directly under your hero
Visitors can't tell what you do from the above-fold content. A single explanatory line can fix this.
Messaging Clarity
CTA Analysis
C+ (57/100)Total CTAs
2
Above Fold
2
Best CTA
Tier 3
What Do You Sell?
D (34/100)In 5 words:
Report awards
Hero
absentMeta Description
specificFierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
ICP Clarity
C (50/100)Detected audience
decentMedia / Content / Publishing, executive
Pricing Page
F (0/100)No pricing page detected.
How You Compare
vs. other Media / Content / Publishing sites in the index
| Dimension | fiercepharma.com | keap.com | zight.com | infusionsoft.… | managewp.com |
|---|---|---|---|---|---|
| Overall | 37 | 87-50 | 87-50 | 87-50 | 86-49 |
| Clarity | 34 | 59-25 | 100-66 | 59-25 | 100-66 |
| CTA | 57 | 75-18 | 60 | 75-18 | 75-18 |
| ICP | 50 | 46 | 91-41 | 46 | 15+35 |
| 1st Impr. | 20 | 60-40 | 60-40 | 60-40 | 52-32 |
| Pricing | 0 | 95-95 | 80-80 | 95-95 | 100-100 |
What We Analyzed
Title
Fierce Pharma Biopharma News & Insights
Word count
331
More in Media / Content / Publishing
View Media / Content / Publishing benchmarks →Track Your Progress
Last scanned 49 days ago. Time to check if your homepage has improved.
fiercepharma.com scored 37/100.
We fix exactly this. Messaging, CTAs, positioning. Ready-to-ship, not a slide deck.
Work with us